Basic science for the clinician 35 -: CD1, invariant NKT (iNKT) cells, and γδ T-cells

被引:8
|
作者
Sigal, LH
机构
[1] Bristol Myers Squibb, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Rheumatol & Connect Tissue Res, Dept Med, New Brunswick, NJ USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08903 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, New Brunswick, NJ 08903 USA
关键词
CD1; gamma delta T-cells; invariant NKT cell; phosphoantigens; lipid antigens;
D O I
10.1097/01.rhu.0000191149.21528.f7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As noted in previous articles in this series, the very heterogeneous MHC class I and II molecules present peptide antigens to T-cells. However, there is another family of less heterogeneous MHC-related molecules. CD11 molecules present lipid antigens, oftentimes to 2 other distinct families of T-cells: gamma delta T-cells (named because they bear a T-cell antigen receptor consisting of a gamma chain and a delta chain rather than the a chain/beta chain heterodimer on most T-cells) and iNKT cells (T-cells that bear markers previously defined on natural killer cells). CD1 molecules and the gamma delta T-cells and iNKT cells to which they present antigens have fundamental responsibilities for immune surveillance over intracellular pathogens and serve other roles that place them at the boundary between innate and acquired immunity. The gamma delta T-cell has been implicated in the pathogenesis of many diseases, rheumatologic and otherwise, suggesting that better understanding of these cells, and of CD1 molecules, may help us explain the immunopathogenesis of some inflammatory diseases and how to craft more targeted therapies in many fields of medicine.
引用
收藏
页码:336 / 339
页数:4
相关论文
共 50 条
  • [41] Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)
    Matthew J. Hadfield
    Howard Safran
    Marco A. Purbhoo
    Joseph E. Grossman
    Jennifer S. Buell
    Benedito A. Carneiro
    Oncogene, 2024, 43 : 758 - 762
  • [42] Mouse CD1 polymorphism affect the development of NK T cells
    Wang, B
    Chen, YH
    Chun, T
    Milligan, CE
    Wang, CR
    FASEB JOURNAL, 2000, 14 (06): : A1056 - A1056
  • [43] Donor-unrestricted T cells in the human CD1 system
    Shouxiong Huang
    D. Branch Moody
    Immunogenetics, 2016, 68 : 577 - 596
  • [44] Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)
    Hadfield, Matthew J.
    Safran, Howard
    Purbhoo, Marco A.
    Grossman, Joseph E.
    Buell, Jennifer S.
    Carneiro, Benedito A.
    ONCOGENE, 2024, 43 (10) : 758 - 762
  • [45] Donor-unrestricted T cells in the human CD1 system
    Huang, Shouxiong
    Moody, D. Branch
    IMMUNOGENETICS, 2016, 68 (08) : 577 - 596
  • [46] Molecular recognition of CD1 antigen complexes by αβ T cells.
    Melian, A
    Vincent, M
    Levin, S
    Almo, S
    Brenner, M
    Porcelli, S
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S382 - S382
  • [47] Activation of human T cells by CD1 and self-lipids
    de Jong, Annemieke
    IMMUNOLOGICAL REVIEWS, 2015, 267 (01) : 16 - 29
  • [48] Use of dendritic cells and CD4+ T-cells to expand γδ T-cells for immunotherapy
    Ye, Z
    Rich, IN
    Lamb, LS
    Harris, WG
    Lee, C
    Gee, AP
    Henslee-Downey, PJ
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 743 - 743
  • [49] Primary immunodeficiency associated with defects in CD1 and CD1-restricted T cells
    Zeissig, Sebastian
    Blumberg, Richard S.
    YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY III, 2012, 1250 : 14 - 24
  • [50] Antibodies to CD1d enhance thymic expression of invariant NKT TCR and increase the presence of NOD thymic invariant NKT cells
    White, Todd C.
    Chauhan, Vandana
    Middlebrook, Aaron J.
    Im, Jin S.
    DeLuca, Dominick
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2008, 32 (08): : 943 - 956